Detalhe da pesquisa
1.
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.
Blood
; 143(5): 444-455, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883802
2.
Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice.
Blood
; 139(21): 3194-3203, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358299
3.
Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels.
Arterioscler Thromb Vasc Biol
; 43(7): e254-e269, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128921
4.
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit.
Haemophilia
; 29(6): 1483-1489, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707428
5.
A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.
Blood
; 135(19): 1704-1717, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315384
6.
COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.
Arterioscler Thromb Vasc Biol
; 41(1): 401-414, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196292
7.
Elevated hematocrit enhances platelet accumulation following vascular injury.
Blood
; 129(18): 2537-2546, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251913
8.
Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury.
J Hepatol
; 64(1): 53-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325534
9.
VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice.
Arterioscler Thromb Vasc Biol
; 40(8): 1952-1954, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580630
10.
Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasma.
Res Pract Thromb Haemost
; 8(1): 102337, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426025
11.
Novel genetic regulators of fibrinogen synthesis identified by an in vitro experimental platform.
J Thromb Haemost
; 21(3): 522-533, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696182
12.
Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
J Thromb Haemost
; 21(3): 467-479, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696199
13.
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia.
Blood Adv
; 7(6): 900-908, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044391
14.
Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
J Trauma Acute Care Surg
; 93(5): 579-587, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687811
15.
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.
J Thromb Haemost
; 19(1): 221-232, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001565
16.
Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
Res Pract Thromb Haemost
; 4(1): 111-116, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989092
17.
Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.
J Med Chem
; 62(7): 3513-3523, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852892
18.
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.
Blood Adv
; 2(10): 1076-1088, 2018 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760205
19.
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
Blood Adv
; 2(1): 25-35, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29344582
20.
Cystamine preparations exhibit anticoagulant activity.
PLoS One
; 10(4): e0124448, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25915545